Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v3.19.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
EXPENSES      
Research and development $ 5,868 $ 3,101 $ 286
General and administrative 6,945 3,531 1,428
Total operating expenses 12,813 6,632 1,714
OTHER INCOME (EXPENSE)      
Interest income 171 21  
Bargain purchase gain [note 2]   1,272  
Contingent value rights recovery [note 2]   200  
Gain on warrants   150  
Loss on disposition of intangible asset [note 5]   (8,610)  
Other expenses (45) (35) (24)
Total other income 126 (7,002) (24)
Net loss before income taxes (12,687) (13,634) (1,738)
Recovery of deferred income taxes [note 5]   3,051 504
Net Loss (12,687) (10,583) (1,234)
OTHER COMPREHENSIVE INCOME      
Net unrealized gain on foreign exchange     4
Total other comprehensive income (loss) (1)   4
Comprehensive loss $ (12,687) $ (10,583) $ (1,230)
Basic and diluted net loss per common share [note 12 [g]] $ (3.61) $ (22.07) $ (581.25)
Shares used in computation of basic and diluted net loss per common share [note 12 [g]] 3,510,217 479,442 2,123